Amgen Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. (AMGN) slipped 1.16% to $265.88 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.06% to 3,719.89 and Dow Jones Industrial Average falling 0.46% to 32,001.25. This was the stock's second consecutive day of losses. Amgen Inc. closed $9.00 below its 52-week high ($274.88), which the company reached on November 2nd.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.17% to $170.72, Roche Holding AG Part. Cert. rose 2.28% to $328.32, and Pfizer Inc. (PFE) fell 0.21% to $46.57. Trading volume (2.8 M) eclipsed its 50-day average volume of 2.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 3, 2022.
(END) Dow Jones Newswires
November 03, 2022 16:36 ET (20:36 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.